The industry trend in neurovascular devices

NeuroInvention is an endovascular treatment of neurological diseases that has recently become a deep foundation for neurological expertise, providing patients with highly advanced clinical services that have surpassed treatment a few years ago. This advance in endovascular therapy has led to an increase in the market for neurovascular devices. The beginning of neurovascular surgery dates back to 1904 and Dawbarn demonstrated that intra-arterial embolization of liquid paraffin is open to embolization of the neck and head malignancies. Lussenhop and Velasquez introduced the right intracranial vascular catheter in 1964, adding new impetus to the market for neurovascular devices.

The prevalence of stroke | The impact of proportions on the needs of the neurovascular device industry

The disruptive trend in the healthcare industry is witnessing the shift in the paradigm of its methods, one of the profound factors affecting the industry trend in neurovascular devices. Another major driver behind the business portfolio is the exponential increase in stroke rates globally. In fact, the statistics on the prevalence of stroke are cause for concern, especially in the United States. A survey by the American Heart Association (AHA) shows that nearly 795,000 people are struck by a stroke each year. The data further claims that the disease is one of the top five causes of death in the United States, causing 129,000 person-years of casualties. The main contributor to the treatment of disorders is their one-time costs and lengthy surgical procedures. It is documented that the total costs associated with cardiovascular disease and stroke exceed $ 320 billion annually. In view of the fact that people over the age of 60 are more susceptible to stroke, it is expected that the expansion of the elderly population base will further promote the commercialization of the neurovascular equipment market. In a recent report, the Centers for Disease Control and Prevention claimed that nearly 87% of all strokes were ischemic, due to obstruction of blood flow to the brain. The disease has been found to be successfully solved using endovascular surgery, which is driving the needs of the neurovascular device industry.

With the advent of technology, endovascular treatment of ischemic stroke continues to evolve. With a wide range of products, the competition in the fierce competitive landscape is quite perceptible. In the next few years, the market for neurovascular devices is expected to open up new opportunities for new entrants into the commercial space.